Drugs / AT-1965
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06234098 | Feb 2024 → Dec 2026 expected | neoplasm | Alyssum Therapeutics | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AT-1965 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06234098 ↗ |
| Route | Intravenous | “AT-1965 Liposome Injection administered intravenously once weekly for the first 3 weeks (Days 1, 8 and 15) of a 4 week cycle.” NCT06234098 ↗ |